TherapeuticsMD has filed a notice of an exempt offering of securities to raise $5,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, TherapeuticsMD is raising $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Marlan Walker played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About TherapeuticsMD
TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD and BocaGreenMD brands.
To learn more about TherapeuticsMD, visit http://www.therapeuticsmd.com/
Contact:
Marlan Walker, Chief Executive Officer
561-961-1900
https://www.linkedin.com/in/marlan-w-93a5351/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.